Doxepin: A Medication for Insomnia and Depression
Doxepin is a tricyclic compound that functions primarily as a histamine H1 receptor antagonist at low doses (3-6 mg) for treating insomnia, and as an antidepressant at higher doses (10-150 mg) for treating depression, anxiety, and related conditions. 1
Low-Dose Doxepin for Insomnia
Mechanism of Action
- At low doses (1-6 mg), doxepin acts as a highly selective histamine H1 receptor antagonist, which promotes sleep initiation and maintenance 2
- This selective H1 antagonism differentiates low-dose doxepin from its action at higher antidepressant doses
Efficacy for Insomnia
- Particularly effective for sleep maintenance insomnia rather than sleep initiation problems 3
- Clinical trials demonstrate significant improvements in:
- Wake time after sleep onset (WASO): Mean reduction of 22-23 minutes compared to placebo 4
- Total sleep time (TST): Mean improvement of 26-32 minutes compared to placebo 4
- Sleep efficiency: Clinically significant improvements at both 3 mg and 6 mg doses 4
- Sleep quality: Small-to-moderate improvement compared to placebo 4
Dosing for Insomnia
- Recommended doses: 3 mg or 6 mg taken once daily before bedtime 4
- Clinical guidelines recommend:
Safety Profile for Low-Dose Use
- Generally well-tolerated with minimal side effects at low doses 2
- Most common side effects include mild somnolence and headache, often at placebo level 5
- No evidence of:
Higher-Dose Doxepin for Depression and Anxiety
Indications
- FDA-approved for:
- Psychoneurotic patients with depression and/or anxiety
- Depression and/or anxiety associated with alcoholism
- Depression and/or anxiety associated with organic disease
- Psychotic depressive disorders with associated anxiety 1
Mechanism at Higher Doses
- At antidepressant doses (10-150 mg), doxepin affects multiple neurotransmitter systems:
- Prevents reuptake of norepinephrine at nerve terminals
- Has anticholinergic, antiserotonin, and antihistamine effects 1
Dosing for Depression/Anxiety
- Typical therapeutic range: 10-150 mg daily 1
- At doses above 150 mg/day, may block antihypertensive effects of certain medications 1
Safety Considerations for Higher Doses
- Black box warning: Increased risk of suicidal thinking and behavior in children, adolescents, and young adults 1
- Common side effects at higher doses:
- Dry mouth
- Drowsiness
- Constipation
- Anticholinergic effects 6
- Not recommended for use in children under 12 years 1
Clinical Decision-Making Algorithm
For insomnia (particularly sleep maintenance):
- First-line: Non-pharmacological approaches (CBT-I or BBT-I) 4
- If non-pharmacological approaches fail or are unavailable:
- Consider low-dose doxepin (3-6 mg) for short-term use
- Start with 3 mg; increase to 6 mg if needed and tolerated
- Monitor for effectiveness and side effects
For depression and/or anxiety:
- Consider standard antidepressant doses (10-150 mg)
- Start at lower doses and titrate based on response
- Monitor closely for side effects and suicidality, especially in younger patients
Important Caveats and Precautions
- Contraindicated in individuals with hypersensitivity to the drug 1
- Use with caution in patients with:
- Cardiovascular disease (though better tolerated than some other tricyclics) 6
- Glaucoma or urinary retention (due to anticholinergic effects at higher doses)
- Not approved for pediatric use 1
- Patients started on antidepressant doses should be monitored for clinical worsening, suicidality, or unusual changes in behavior 1
Low-dose doxepin represents a different approach to insomnia treatment compared to traditional hypnotics, with its selective histamine antagonism providing benefits for sleep maintenance with minimal side effects when used appropriately.